INVESTIGADORES
IRAZOQUI Fernando Jose
artículos
Título:
The immune response to Thomsen-Friedenreich disaccharide, and glycan engineering.
Autor/es:
FERNANDO JOSE IRAZOQUI; SENDRA VG,; LARDONE RD,; NORES GA.,
Revista:
IMMUNOLOGY AND CELL BIOLOGY
Referencias:
Año: 2005 vol. 83 p. 405 - 412
ISSN:
0818-9641
Resumen:
© 2005 Australasian Society for Immunology Inc.
Immune response to ThomsenFriedenreich disaccharide and glycan engineering
FERNANDO J IRAZOQUI, VICTOR G SENDRA, RICARDO D LARDONE and
GUSTAVO A NORES
CIQUIBIC-CONICET/Department of Biological Chemistry, Faculty of Chemical Sciences, National University of
Cordoba, Ciudad Universitaria, Cordoba, Argentina
Summary
Cancer-associated mucins show frequent alterations of their oligosaccharide chain profile, with a
switch to unmask normally cryptic O-glycan backbone and core regions. Epithelial tumour cells typically show
overexpression of the uncovered Galタ1-3GalNAcソ-O-Ser/Thr (Core 1) structure, known as the T antigen or the
ThomsenFriedenreich antigen, the oligosaccharide chain of which is called the ThomsenFriedenreich disaccharide
(TFD). T antigen expression has been associated with immunosuppression, metastasis dissemination, and the
proliferation of cancer cells. Several different strategies have been used to trigger a specific immune response to
TFD. Natural T antigen and synthetic TFD residues have low immunodominance. In the T antigen, flexibility of the
glycosidic bond reduces the immunogenicity of the sugar residue. Enhanced rigidity should favour certain glycan
conformations and thereby improve TFD immunotargeting. We propose the term glycan engineering for this
approach. Such engineering of TFD should reduce the flexibility of its glycan moiety and thereby enhance its
stability, rigidity and immunogenicity.
ThomsenFriedenreich antigen, the oligosaccharide chain of which is called the ThomsenFriedenreich disaccharide
(TFD). T antigen expression has been associated with immunosuppression, metastasis dissemination, and the
proliferation of cancer cells. Several different strategies have been used to trigger a specific immune response to
TFD. Natural T antigen and synthetic TFD residues have low immunodominance. In the T antigen, flexibility of the
glycosidic bond reduces the immunogenicity of the sugar residue. Enhanced rigidity should favour certain glycan
conformations and thereby improve TFD immunotargeting. We propose the term glycan engineering for this
approach. Such engineering of TFD should reduce the flexibility of its glycan moiety and thereby enhance its
stability, rigidity and immunogenicity.
overexpression of the uncovered Galタ1-3GalNAcソ-O-Ser/Thr (Core 1) structure, known as the T antigen or the
ThomsenFriedenreich antigen, the oligosaccharide chain of which is called the ThomsenFriedenreich disaccharide
(TFD). T antigen expression has been associated with immunosuppression, metastasis dissemination, and the
proliferation of cancer cells. Several different strategies have been used to trigger a specific immune response to
TFD. Natural T antigen and synthetic TFD residues have low immunodominance. In the T antigen, flexibility of the
glycosidic bond reduces the immunogenicity of the sugar residue. Enhanced rigidity should favour certain glycan
conformations and thereby improve TFD immunotargeting. We propose the term glycan engineering for this
approach. Such engineering of TFD should reduce the flexibility of its glycan moiety and thereby enhance its
stability, rigidity and immunogenicity.
ThomsenFriedenreich antigen, the oligosaccharide chain of which is called the ThomsenFriedenreich disaccharide
(TFD). T antigen expression has been associated with immunosuppression, metastasis dissemination, and the
proliferation of cancer cells. Several different strategies have been used to trigger a specific immune response to
TFD. Natural T antigen and synthetic TFD residues have low immunodominance. In the T antigen, flexibility of the
glycosidic bond reduces the immunogenicity of the sugar residue. Enhanced rigidity should favour certain glycan
conformations and thereby improve TFD immunotargeting. We propose the term glycan engineering for this
approach. Such engineering of TFD should reduce the flexibility of its glycan moiety and thereby enhance its
stability, rigidity and immunogenicity.
O-glycan backbone and core regions. Epithelial tumour cells typically show
overexpression of the uncovered Galタ1-3GalNAcソ-O-Ser/Thr (Core 1) structure, known as the T antigen or the
ThomsenFriedenreich antigen, the oligosaccharide chain of which is called the ThomsenFriedenreich disaccharide
(TFD). T antigen expression has been associated with immunosuppression, metastasis dissemination, and the
proliferation of cancer cells. Several different strategies have been used to trigger a specific immune response to
TFD. Natural T antigen and synthetic TFD residues have low immunodominance. In the T antigen, flexibility of the
glycosidic bond reduces the immunogenicity of the sugar residue. Enhanced rigidity should favour certain glycan
conformations and thereby improve TFD immunotargeting. We propose the term glycan engineering for this
approach. Such engineering of TFD should reduce the flexibility of its glycan moiety and thereby enhance its
stability, rigidity and immunogenicity.
ThomsenFriedenreich antigen, the oligosaccharide chain of which is called the ThomsenFriedenreich disaccharide
(TFD). T antigen expression has been associated with immunosuppression, metastasis dissemination, and the
proliferation of cancer cells. Several different strategies have been used to trigger a specific immune response to
TFD. Natural T antigen and synthetic TFD residues have low immunodominance. In the T antigen, flexibility of the
glycosidic bond reduces the immunogenicity of the sugar residue. Enhanced rigidity should favour certain glycan
conformations and thereby improve TFD immunotargeting. We propose the term glycan engineering for this
approach. Such engineering of TFD should reduce the flexibility of its glycan moiety and thereby enhance its
stability, rigidity and immunogenicity.
タ1-3GalNAcソ-O-Ser/Thr (Core 1) structure, known as the T antigen or the
ThomsenFriedenreich antigen, the oligosaccharide chain of which is called the ThomsenFriedenreich disaccharide
(TFD). T antigen expression has been associated with immunosuppression, metastasis dissemination, and the
proliferation of cancer cells. Several different strategies have been used to trigger a specific immune response to
TFD. Natural T antigen and synthetic TFD residues have low immunodominance. In the T antigen, flexibility of the
glycosidic bond reduces the immunogenicity of the sugar residue. Enhanced rigidity should favour certain glycan
conformations and thereby improve TFD immunotargeting. We propose the term glycan engineering for this
approach. Such engineering of TFD should reduce the flexibility of its glycan moiety and thereby enhance its
stability, rigidity and immunogenicity.